154 related articles for article (PubMed ID: 31372009)
1. Successful treatment of
Feugray G; Krzisch D; Dehais M; Razakandrainibe R; Gargala G; Favennec L; Lepretre S; Camus V; Costa D
Infect Drug Resist; 2019; 12():2015-2018. PubMed ID: 31372009
[No Abstract] [Full Text] [Related]
2. Fatal Disseminated Infection by Trichosporon asahii Under Voriconazole Therapy in a Patient with Acute Myeloid Leukemia: A Review of Breakthrough Infections by Trichosporon spp.
Ramírez I; Moncada D
Mycopathologia; 2020 Apr; 185(2):377-388. PubMed ID: 31853871
[TBL] [Abstract][Full Text] [Related]
3. Fungemia due to Trichosporon asahii in a neutropenic child refractory to amphotericin B: clearance with voriconazole.
Antachopoulos C; Papakonstantinou E; Dotis J; Bibashi E; Tamiolaki M; Koliouskas D; Roilides E
J Pediatr Hematol Oncol; 2005 May; 27(5):283-5. PubMed ID: 15891566
[TBL] [Abstract][Full Text] [Related]
4. The epidemiology, genotypes, antifungal susceptibility of Trichosporon species, and the impact of voriconazole on Trichosporon fungemia patients.
Kuo SH; Lu PL; Chen YC; Ho MW; Lee CH; Chou CH; Lin SY
J Formos Med Assoc; 2021 Sep; 120(9):1686-1694. PubMed ID: 33358563
[TBL] [Abstract][Full Text] [Related]
5. Successful treatment of breakthrough Trichosporon asahii fungemia with voriconazole in a patient with acute myeloid leukemia.
Asada N; Uryu H; Koseki M; Takeuchi M; Komatsu M; Matsue K
Clin Infect Dis; 2006 Aug; 43(4):e39-41. PubMed ID: 16838224
[TBL] [Abstract][Full Text] [Related]
6. Breakthrough Trichosporon asahii fungemia in neutropenic patient with acute leukemia while receiving caspofungin.
Bayramoglu G; Sonmez M; Tosun I; Aydin K; Aydin F
Infection; 2008 Feb; 36(1):68-70. PubMed ID: 17882360
[TBL] [Abstract][Full Text] [Related]
7. Micafungin Breakthrough Fungemia in Patients with Hematological Disorders.
Kimura M; Araoka H; Yamamoto H; Nakamura S; Nagi M; Yamagoe S; Miyazaki Y; Ogura S; Mitsuki T; Yuasa M; Kaji D; Kageyama K; Nishida A; Taya Y; Shimazu H; Ishiwata K; Takagi S; Yamamoto G; Asano-Mori Y; Uchida N; Wake A; Taniguchi S; Yoneyama A
Antimicrob Agents Chemother; 2018 May; 62(5):. PubMed ID: 29530846
[TBL] [Abstract][Full Text] [Related]
8. Fatal disseminated Trichosporon asahii fungemia in a child with acute lymphoblastic leukemia and a morbilliform eruption.
Nguyen JK; Schlichte MJ; Schady D; Pourciau CY
Pediatr Dermatol; 2018 Jan; 35(1):e86-e87. PubMed ID: 29266471
[TBL] [Abstract][Full Text] [Related]
9. Epidemiological study of
Li H; Guo M; Wang C; Li Y; Fernandez AM; Ferraro TN; Yang R; Chen Y
Epidemiol Infect; 2020 Jul; 148():e169. PubMed ID: 32703332
[TBL] [Abstract][Full Text] [Related]
10. [Fungemia due to Trichosporon asahii in a patient with hematological malignancy].
Odero V; Galán-Sánchez F; García-Agudo L; García-Tapia AM; Guerrero-Lozano I; Rodríguez-Iglesias MA
Rev Iberoam Micol; 2015; 32(1):59-61. PubMed ID: 24071639
[TBL] [Abstract][Full Text] [Related]
11. Catheter-Related Trichosporon asahii Bloodstream Infection in a Neutropenic Patient with Myelodysplastic Syndrome.
Go SE; Lee KJ; Kim Y; Choi JK; Kim YJ; Lee DG
Infect Chemother; 2018 Jun; 50(2):138-143. PubMed ID: 29968981
[TBL] [Abstract][Full Text] [Related]
12. Trichosporon asahii fungemia and COVID-19 co-infection: An emerging fungal pathogen; case report and review of the literature.
Ali GA; Husain A; Salah H; Goravey W
IDCases; 2021; 25():e01244. PubMed ID: 34367918
[TBL] [Abstract][Full Text] [Related]
13. Molecular identification and susceptibility testing of Trichosporon isolates from a Brazilian hospital.
Araujo Ribeiro M; Alastruey-Izquierdo A; Gomez-Lopez A; Rodriguez-Tudela JL; Cuenca-Estrella M
Rev Iberoam Micol; 2008 Dec; 25(4):221-5. PubMed ID: 19071890
[TBL] [Abstract][Full Text] [Related]
14. Trichosporon asahii, sepsis, and secondary hemophagocytic lymphohistiocytosis in children with hematologic malignancy.
Karapinar DY; Karadaş N; Yazici P; Polat SH; Karapinar B
Pediatr Hematol Oncol; 2014 Apr; 31(3):282-4. PubMed ID: 24383917
[TBL] [Abstract][Full Text] [Related]
15. Trichosporon asahii fungemia in a patient with non-hematological malignancy.
Karabay O; Madariaga MG; Kocoglu E; Ince N; Kandirali E
Jpn J Infect Dis; 2006 Apr; 59(2):129-31. PubMed ID: 16632916
[TBL] [Abstract][Full Text] [Related]
16. [Nosocomial infection due to Trichosporon asahii in a critical burned patient].
Tamayo Lomas L; Domínguez-Gil González M; Martín Luengo AI; Eiros Bouza JM; Piqueras Pérez JM
Rev Iberoam Micol; 2015; 32(4):257-60. PubMed ID: 25579090
[TBL] [Abstract][Full Text] [Related]
17. Trichosporon asahii causing nosocomial urinary tract infections in intensive care unit patients: genotypes, virulence factors and antifungal susceptibility testing.
Sun W; Su J; Xu S; Yan D
J Med Microbiol; 2012 Dec; 61(Pt 12):1750-1757. PubMed ID: 22956749
[TBL] [Abstract][Full Text] [Related]
18.
Cronyn V; Howard J; Chiang L; Le L; Tims-Cook Z; Gertz AM
Case Rep Infect Dis; 2021; 2021():6841393. PubMed ID: 34925928
[No Abstract] [Full Text] [Related]
19. Fatal disseminated Trichosporon asahii infection in a child with acute lymphoblastic leukemia.
Thibeault R; Champagne M; de Repentigny L; Fournet JC; Tapiero B; Moghrabi A; Ovetchkine P
Can J Infect Dis Med Microbiol; 2008 Mar; 19(2):203-5. PubMed ID: 19352453
[TBL] [Abstract][Full Text] [Related]
20. Successful treatment of breakthrough disseminated
Karigane D; Sakurai M; Matsuyama E; Ide K; Yamamoto-Takeuchi S; Inazumi T; Kohashi S
Med Mycol Case Rep; 2018 Jun; 20():1-3. PubMed ID: 29264110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
